Pharmacokinetic and Pharmacodynamic Effects of Passive Cannabis Inhalation
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This primary aim of this study is to assess the effects of passive (second-hand) inhalation
of cannabis smoke on toxicological analysis of "native" oral fluid (saliva), urine and blood
specimens. The results of this study will help inform the validity of oral fluid as a
biomarker of cannabis exposure and to determine whether, and for how long, passive inhalation
of cannabis smoke could result in a positive toxicology result.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University Ryan Vandrey
Collaborators:
RTI International Substance Abuse and Mental Health Services Administration (SAMHSA)